GPAT vs JPM

JPMorgan Chase & Co.

(JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 16. 0x versus GP-Act III Acquisition Corp. at 26. 4x.

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +118. 2%, compared to +8. 5% for GP-Act III Acquisition Corp. (GPAT). Over 10 years, the gap is even starker: JPM returned +465. 8% versus GPAT's +8. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), GP-Act III Acquisition Corp.

(GPAT) is the lower-risk stock at -0. 02β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately -4635% more volatile than GPAT relative to the S&P 500. On balance sheet safety, GP-Act III Acquisition Corp. (GPAT) carries a lower debt/equity ratio of 0% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

On earnings-per-share growth, the picture is similar: JPMorgan Chase & Co.

grew EPS 1. 5% year-over-year, compared to -12. 8% for GP-Act III Acquisition Corp.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus 0. 0% for GP-Act III Acquisition Corp. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 0. 0% for GPAT. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, JPM (1.

9% yield) pays a dividend. GPAT does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, GP-Act III Acquisition Corp.

(GPAT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 02)). Both have compounded well over 10 years (GPAT: +8. 5%, JPM: +465. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: GPAT is a small-cap quality compounder stock; JPM is a large-cap deep-value stock. JPM pays a dividend while GPAT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.